Equity Overview
Price & Market Data
Price: $0.352
Daily Change: $0.00 / 0.00%
Daily Range: $0.339 - $0.379
Market Cap: $7,242,681
Daily Volume: 98,672
Performance Metrics
1 Week: -6.41%
1 Month: -20.29%
3 Months: -36.94%
6 Months: -60.00%
1 Year: -82.49%
YTD: -36.94%
Company Details
Employees: 8
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.